Please provide your email address to receive an email when new articles are posted on . Insurance status contributes to considerable disparities in care quality for patients with head and neck cancer, ...
Split-Dose Cisplatin Plus Atezolizumab for Patients With Urothelial Carcinoma Who Are Considered Ineligible for Full Doses of Cisplatin (SOGUG-AUREA) In patients with mRCC, Medicare was associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results